EnGene Holdings Financial Statements From 2010 to 2024
ENGN Etf | USD 7.92 0.91 12.98% |
Market Capitalization 412.4 M | Earnings Share (2.79) |
Check EnGene Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnGene Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . EnGene financial statements analysis is a perfect complement when working with EnGene Holdings Valuation or Volatility modules.
EnGene |
enGene Holdings Common ETF Price To Book Analysis
EnGene Holdings' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current EnGene Holdings Price To Book | 1.91 X |
Most of EnGene Holdings' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, enGene Holdings Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition |
Based on the latest financial disclosure, enGene Holdings Common has a Price To Book of 1.9144 times. This is much higher than that of the Biotechnology family and significantly higher than that of the Health Care category. The price to book for all United States etfs is notably lower than that of the firm.
enGene Holdings Common Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EnGene Holdings's current stock value. Our valuation model uses many indicators to compare EnGene Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EnGene Holdings competition to find correlations between indicators driving EnGene Holdings's intrinsic value. More Info.enGene Holdings Common is rated below average in price to book as compared to similar ETFs. It is rated below average in beta as compared to similar ETFs . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EnGene Holdings' earnings, one of the primary drivers of an investment's value.About EnGene Holdings Financial Statements
EnGene Holdings investors utilize fundamental indicators, such as revenue or net income, to predict how EnGene Etf might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
EnGene Holdings is entity of United States. It is traded as Etf on NASDAQ exchange.
Pair Trading with EnGene Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnGene Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will appreciate offsetting losses from the drop in the long position's value.Moving against EnGene Etf
0.65 | ME | 23Andme Holding | PairCorr |
0.49 | DOMH | Dominari Holdings | PairCorr |
0.49 | DTIL | Precision BioSciences | PairCorr |
0.43 | VALN | Valneva SE ADR | PairCorr |
0.41 | A | Agilent Technologies | PairCorr |
The ability to find closely correlated positions to EnGene Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnGene Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnGene Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enGene Holdings Common to buy it.
The correlation of EnGene Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnGene Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enGene Holdings Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnGene Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in EnGene Etf
EnGene Holdings financial ratios help investors to determine whether EnGene Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EnGene with respect to the benefits of owning EnGene Holdings security.